Essex Bio-Technology (HKSE:01061) Long-Term Debt : HK$96 Mil (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology Long-Term Debt?

Essex Bio-Technology's Long-Term Debt for the quarter that ended in Dec. 2024 was HK$96 Mil.

Essex Bio-Technology's quarterly Long-Term Debt increased from Dec. 2023 (HK$36 Mil) to Jun. 2024 (HK$69 Mil) and increased from Jun. 2024 (HK$69 Mil) to Dec. 2024 (HK$96 Mil).

Essex Bio-Technology's annual Long-Term Debt declined from Dec. 2022 (HK$382 Mil) to Dec. 2023 (HK$36 Mil) but then increased from Dec. 2023 (HK$36 Mil) to Dec. 2024 (HK$96 Mil).

Essex Bio-Technology Long-Term Debt Historical Data

The historical data trend for Essex Bio-Technology's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essex Bio-Technology Long-Term Debt Chart

Essex Bio-Technology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

354.60

406.49

382.12

36.06

95.55

Essex Bio-Technology Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															382.12	354.97	36.06	68.83	95.55

Essex Bio-Technology (HKSE:01061) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Essex Bio-Technology Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Essex Bio-Technology's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Essex Bio-Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN

Website

http://www.essexbio.com

Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.

Executives

Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin	2101 Beneficial owner

Essex Bio-Technology Headlines

No Headlines